Differential modulation of adhesion molecule expression by hydroxycarbamide in human endothelial cells from the micro- and macrocirculation: potential implications in sickle cell disease vasoocclusive events.
about
Hydroxycarbamide decreases sickle reticulocyte adhesion to resting endothelium by inhibiting endothelial lutheran/basal cell adhesion molecule (Lu/BCAM) through phosphodiesterase 4A activationCoagulation activation in children with sickle cell disease is associated with cerebral small vessel vasculopathy.Mean Platelet Volume can Predict Cerebrovascular Events in Patients with Sickle Cell Anemia.Inflammatory targets of therapy in sickle cell disease.Fetal hemoglobin and hydroxycarbamide moduate both plasma concentration and cellular origin of circulating microparticles in sickle cell anemia children.Novel Use of Hydroxyurea in an African Region With Malaria: Protocol for a Randomized Controlled Clinical Trial.Hydroxyurea responsiveness in β-thalassemic patients is determined by the stress response adaptation of erythroid progenitors and their differentiation propensity.The rationale for using hydroxycarbamide in the treatment of sickle cell disease.The promotion of angiogenesis induced by three-dimensional porous beta-tricalcium phosphate scaffold with different interconnection sizes via activation of PI3K/Akt pathways.Application of strontium-doped calcium polyphosphate scaffold on angiogenesis for bone tissue engineering.
P2860
Q33676406-47DD1B49-1EBD-4B1A-BDBC-EDDCEE37AB68Q35036717-A9D8E052-EE69-440B-B756-B15CCE9A0B3EQ35277610-755E6FF1-F000-46D6-95A1-0C2EBFB22757Q36385224-A2791834-E42E-466D-A38F-4B96716715C9Q36892578-91B82878-1C21-45A3-B062-63BBCF7F7015Q37075880-1D7590D6-6B22-4979-ADA3-0E994A30186BQ40245190-0B7FD509-521D-4016-9B20-421BD11B314EQ42708637-229A1ABA-4778-4F2A-922D-7E83A43B3029Q43197857-E14DB27C-74D5-43C2-A4DC-D40847022C1BQ51829637-DD85A416-02A0-4395-A72D-FF391B4C5835
P2860
Differential modulation of adhesion molecule expression by hydroxycarbamide in human endothelial cells from the micro- and macrocirculation: potential implications in sickle cell disease vasoocclusive events.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Differential modulation of adh ...... disease vasoocclusive events.
@ast
Differential modulation of adh ...... disease vasoocclusive events.
@en
Differential modulation of adh ...... disease vasoocclusive events.
@nl
type
label
Differential modulation of adh ...... disease vasoocclusive events.
@ast
Differential modulation of adh ...... disease vasoocclusive events.
@en
Differential modulation of adh ...... disease vasoocclusive events.
@nl
prefLabel
Differential modulation of adh ...... disease vasoocclusive events.
@ast
Differential modulation of adh ...... disease vasoocclusive events.
@en
Differential modulation of adh ...... disease vasoocclusive events.
@nl
P2093
P2860
P50
P1433
P1476
Differential modulation of adh ...... disease vasoocclusive events.
@en
P2093
Arndt Benecke
François-Xavier Pellay
Michelle Hauchecorne
Pauline Lansiaux
P2860
P304
P356
10.3324/HAEMATOL.2010.026740
P577
2011-01-12T00:00:00Z